ACCP collaborates with ASHP on Cardiology Pharmacy activities.
Series Overview
The Literature Study Module provides immediate access to peer-selected, contemporary articles that are relevant to specialty practice. After learners review the content, they must successfully complete an online assessment to earn recertification credit.
Release date: October 21, 2020
BCCP credit expiration date: April 20, 2021
ACPE credit expiration date: October 20, 2023
Activity Overview
The Literature Study Module is intended for board certified pharmacists in need of recertification credit and is designed based on the content outline developed by the Board of Pharmacy Specialties (BPS). This module consists of 2 online home study activities (see table below). Each activity is designed to assess the learners’ ability to analyze and apply peer-selected contemporary articles to practice.
Module 1A: Antithrombotic Updates: This module focuses on updates on the use of antithrombotics in patients with atrial fibrillation, acute and stable coronary disease, peri-operatively, and/or after percutaneous coronary intervention.
Module 1B: Heart Failure/Cardiovascular Outcomes: This module covers the impact of cardiovascular outcomes of SLGT2 inhibitors, as well as angiotensin-neprilysin inhibition in patients with heart failure.
Learners will be required to review the content and complete the associated online assessments. The learner must be able to correctly answer the questions based upon their interpretation of the content, as well as “baseline specialty specific knowledge and/or easily retrievable information.” For purposes of this Literature Study, “baseline specialty specific knowledge and/or easily retrievable information” is defined as product labeling and well-established standards of practice in the specialty practice.
These activities are part of the ASHP and ACCP professional development program for BCCP recertification approved by the BPS.
Faculty
|
Zachary R. Noel, Pharm.D., BCCP
Assistant Professor
University of Maryland School of Pharmacy
Baltimore, Maryland |
|
Mary Roth, Pharm.D., BCCP, BCPS
Cardiovascular Clinical Pharmacist
University of Virginia Medical Center
Charlottesville, Virginia |
|
Ashley Schenk, Pharm.D., BCPS, BCCP
Cardiology Clinical Pharmacist
University of Kentucky HealthCare
Lexington, Kentucky |
|
Kristin Watson, Pharm.D., BCCP
Associate Professor
University of Maryland School of Pharmacy
Baltimore, Maryland |
Content Matter Experts
|
Christopher Betz, Pharm.D., BCPS, FASHP, FKSHP
Professor, Department of Clinical and Administrative Sciences
Sullivan University College of Pharmacy
Cardiology Clinical Pharmacy Specialist
Jewish Hospital Rudd Heart and Lung Center
Louisville, Kentucky |
|
Steven Dunn, Pharm.D., BCPS-AQ Cardiology, FAHA, FCCP
Pharmacy Clinical Coordinator, Heart & Vascular
University of Virginia Health System
Charlottesville, Virginia |
|
Michelle L. Hilaire, Pharm.D., FCCP, BCPS, BCACP, CDE
Clinical Professor
University of Wyoming School of Pharmacy
Laramie, Wyoming |
|
Tracy Macaulay, Pharm.D., BCPS-AQ Cardiology, BCCP, AACC
Associate Clinical Professor
University of Kentucky College of Pharmacy
Cardiology Clinical Specialist
UKHealthCare and Gill Heart Institute
Lexington, Kentucky |
|
Brent N. Reed, Pharm.D., BCCP
Associate Professor
University of Maryland School of Pharmacy
Baltimore, Maryland |
Conflict of Interest Disclosures
Target Audience
These Literature Studies are designed to help board-certified pharmacists who are seeking recertification credit hours to maintain their Board of Pharmacy Specialties (BPS).
Learning Objectives
Module 1A: Antithrombotic Updates
Module 1B: Heart Failure/Cardiovascular Outcomes
Continuing Pharmacy Education Credit
The American Society of Health-System Pharmacists and American College of Clinical Pharmacy are accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Module 1A: Antithrombotic Updates
Activity Number: 0204-9999-20-971-H01-P
Contact Hours: 4.00
Activity Type: Application-Based Activity
Module 1B: Heart Failure/Cardiovascular Outcomes
Activity Number: 0204-9999-20-972-H01-P
Contact Hours: 4.00
Activity Type: Application-Based Activity
Methods and CE Requirements
ACPE Continuing Pharmacy Education Credit
To be eligible to earn continuing pharmacy education credit, participants must purchase the product, review all content, successfully complete, submit and pass the Web-based posttest associated with each module by October 20, 2023. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment.
National Association of Boards of Pharmacy - CPE Monitor Service
Provided through the collaborative efforts of the National Association of Boards of Pharmacy (NABP), the Accreditation Council for Pharmacy Education (ACPE), and ACPE-accredited providers, the CPE Monitor Service allows you to electronically keep track of continuing pharmacy education (CPE) credits from ACPE-accredited providers. ACPE-accredited providers, like ACCP, are responsible for transmitting this information to NABP to be stored in the CPE Monitor system. Statements of credit will be available at CPE Monitor, nabp.pharmacy/cpe-monitor-service/, within 2–3 business days after completion of this activity. For more information on CPE Monitor please visit nabp.pharmacy/cpe-monitor-service/.
To transfer these credits to CPE Monitor on your behalf your NABP e-Profile ID Number and date of birth must be listed on your ACCP account. To verify or update this information in your ACCP account, visit Licensure/Certification. Be sure to save your changes at the bottom of the page.
Some international pharmacists do not use the CPE Monitor service. To verify or update this information in your ACCP account, visit Licensure/Certification. Check the box “I am an international pharmacist or I am not licensed to practice in the United States, and do not have an NABP e-Profile ID.” Be sure to save your changes at the bottom of the page.
Recertification Credit
Board certified pharmacists are eligible to receive up to 8 hours of recertification credit for completing this activity. To be eligible to earn BCCP recertification credit, participants must purchase the recertification version of this course, review all content, successfully complete, submit and pass the Web-based posttest associated with each module by April 20, 2021. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment.
The passing point to earn BCCP recertification credit is based on an expert analysis of the assessment items in each posttest module. Any posttest submitted before the BCCP posttest deadline that meets this passing point will earn BCCP recertification credits. These credits will be assigned as of the date of test submission. For statements of recertification credit, visit www.bpsweb.org.
All participants must have a Board of Pharmacy Specialties (BPS) board certification credential number, BPS ID Number, and a BPS expiration date on file with ACCP for reporting purposes. To verify or update this information in your ACCP account, visit Licensure/Certification. Be sure to save your changes at the bottom of the page.
Questions regarding the number of hours required for BCCP recertification should be directed to BPS at (202) 429-7591 or www.bpsweb.org.
Technical Requirements
Commercial Support
The American College of Clinical Pharmacy does not solicit or accept external commercial/financial support for its continuing pharmacy education activities. No commercial/financial support has been solicited or accepted for this activity.